Get started
Author

J.M. Vierling

Early Clinical Experience with a Hybrid Bioartificial Liver
1995 · A. A. Demetriou, J. Rozga, et al. · Scandinavian Journal of Gastroenterology · 116
Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation
1997 · L M Petrovic, F G Villamil, et al. · Liver Transplantation and Surgery · 57
PDF
105 Phase 2, Multicenter, Randomized Study of Ast-120 (spherical Carbon Adsorbent) Vs. Lactulose in the Treatment of Low-grade Hepatic Encephalopathy (he)
2009 · P. Pockros, T. Hassanein, et al. · Journal of Hepatology · 25
PDF
Solids, water, and solutes in papillary region of the rat kidney
1969 · Gardner KD, JM Vierling · American Journal of Physiology-Legacy Content · 23
190 Ast-120 (spherical Carbon Adsorbent) in Covert Hepatic Encephalopathy: Results of the Astute Trial
2013 · J.S. Bajaj, M.Y. Sheikh, et al. · Journal of Hepatology · 19
PDF
Safety and efficacy of the fixed-dose combination regimen of MK-3682/grazoprevir/ruzasvir in cirrhotic or non-cirrhotic patients with chronic HCV GT1 infection who previously failed a direct-acting antiviral regimen (C-SURGE)
2017 · H. Wedemeyer, D. Wyles, et al. · Journal of Hepatology · 11
1430 Safety and Efficacy of Boceprevir/peginterferon/ Ribavirin (boc/p/r) Combination Therapy for Chronic Hcv G1 Patients With Compensated Cirrhosis: a Meta-analysis of Five Phase 3 Clinical Trials
2013 · J.M. Vierling, S. Zeuzem, et al. · Journal of Hepatology · 11
PDF
Validation of serum fibrosis marker panels in patients with primary sclerosing cholangitis (PSC) in a randomized trial of simtuzumab
2015 · Christopher L. Bowlus, Kalpesh Patel, et al. · Hepatology · 3
Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
1996 · L S Sher, C A Cosenza, et al. · PubMed · 3
Long-term efficacy and safety of elafibranor in primary biliary cholangitis: Interim results from the open-label extension of the ELATIVE trial up to 3 years
2025 · K V Kowdley, C L Bowlus, et al. · Zeitschrift für Gastroenterologie · 1
1241 Pre-transplant adjuvant therapy for hepatocellular carcinoma results in a survival disadvantage
2003 · E CAVAZZONI, M MEEHAN, et al. · Hepatology · 1
Wirksamkeit der Obeticholsäure-Behandlung bei Patienten mit primär biliärer Cholangitis (PBC) und Zirrhose
2017 · T Berg, JM Vierling, et al. · Zeitschrift für Gastroenterologie
PTU-100 Efficacy of obeticholic acid treatment in patients with primary biliary cholangitis with cirrhosis
2017 · JM Vierling, G Hirschfield, et al.
Treatment efficacy and safety of low dose seladelpar, a selective PPAR-δ agonist, in patients with primary biliary cholangitis: Twelve-week interim analysis of an international, randomized, dose ranging, phase 2 study.
2017 · Gideon M. Hirschfield, Christopher L. Bowlus, et al.
Safety and tolerability of elbasvir/grazoprevir in patients with chronic hepatitis C (HCV) infection: Integrated analysis of phase 2-3 trials
2016 · Barr, E, Dusheiko, GM, et al. · UCL Discovery (University College London)
205 Long Term Outcomes of Portopulmonary Hypertension (poph) After Orthotopic Liver Transplantation (olt)
2013 · S.A. Khaderi, R. Khan, et al. · Journal of Hepatology
248 Fasting Ammonia (nh3) as a Predictor of Hepatic Encephalopathy (he) Events
2013 · J.M. Vierling, M. Mokhtarani, et al. · Journal of Hepatology
1235 Adjuvant chemotherapy does not affect survival in incidental hepatocellular carcinoma
2003 · W AYOUB, J VIERLING, et al. · Hepatology
1267 Predicting post-transplant survival with hepatocellular carcinoma: an assessment of current staging systems and individual parameters
2003 · E CAVAZZONI, M MEEHAN, et al. · Hepatology
Works count: 19
Citation count: 270
H-index: 7
I10-index: 7
Year
Topic
Type